Filovirus tropism: Cellular molecules for viral entry

Frontiers in Microbiology

Volumn 3, Issue FEB, 2012, Pages

  Takada, Ayato ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Ebola virus; Filovirus; Marburg virus; Receptor; Tropism; Viral glycoprotein

Indexed keywords

EID: 84860424652     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2012.00034     Document Type: Review

References (83)

1. Allela, L., Boury, O., Pouillot, R., Délicat, A., Yaba, P., Kumulungui, B., Rou-quet, P., Gonzalez, J. P., and Leroy, E. M. (2005). Ebola virus antibody prevalence in dogs and human risk. Emerging Infect Dis. 11, 385-390.
2. Alvarez, C. P., Lasala, F., Carrillo, J., Muñiz, O., Corbí, A. L., and Delgado, R. (2002). C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. J. Virol. 76, 6841-6844.
3. Barrette, R. W., Metwally, S. A., Rowland, J. M., Xu, L., Zaki, S. R., Nichol, S.T., Rollin, P.E., Towner, J.S., Shieh, W. J., Batten, B., Sealy, T. K., Carrillo, C., Moran, K. E., Bracht, A. J., Mayr, G. A., Sirios-Cruz, M., Catbagan, D. P., Lautner, E. A., Ksiazek, T. G., White, W. R., and McIntosh, M. T. (2009). Discovery of swine as a host for the Reston ebolavirus. Science 325, 204-206.
4. Becker, S., Spiess, M., and Klenk, H. D. (1995). The asialoglycoprotein receptor is a potential liver-specific receptor for Marburg virus. J. Gen. Virol. 76, 393-399.
5. Bharat, T. A., Riches, J. D., Kolesnikova, L., Welsch, S., Krähling, V., Davey, N., Parsy, M. L., Becker, S., and Briggs, J. A. (2011). Cryo-electron tomography of Marburg virus particles and their morphogenesis within infected cells. PLoSBiol. 9,e1001 196. doi:10.1371/journal.pbio.1001196
6. Bowen, E. T., Platt, G. S., Lloyd, G., Raymond, R. T., and Simpson, D. I. (1980). A comparative study of strains of Ebola virus isolated from southern Sudan and northern Zaire in 1976. J. Med. Virol. 6, 129-138.
7. Bray, M., Davis, K., Geisbert, T., Schmaljohn, C., and Huggins, J. (1998). A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever. J. Infect. Dis. 178, 651-661.
8. Bukreyev, A., Rollin, P. E., Tate, M. K., Yang, L., Zaki, S. R., Shieh, W. J., Murphy, B. R., Collins, P. L., and Sanchez, A. (2007). Successful topical respiratory tract immunization of primates against Ebola virus. J. Virol. 81,6379-6388.
9. Carette, J. E., Raaben, M., Wong, A. C., Herbert, A. S., Obernosterer, G., Mulherkar, N., Kuehne, A. I., Kranzusch, P. J., Griffin, A. M., Ruthel, G., Dal Cin, P., Dye, J. M., Whelan, S. P., Chandran, K., and Brummelkamp, T. R. (2011). Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature 477, 340-343.
10. Chan, S. Y., Empig, C. J., Welte, F. J., Speck, R. F., Schmaljohn, A., Kreisberg, J. F., and Goldsmith, M. A. (2001). Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses. Cell 106, 117-126.
11. Chan, S. Y., Speck, R. F., Ma, M. C., and Goldsmith, M. A. (2000). Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses. J. Virol.74, 4933-4937.
12. Chandran, K., Sullivan, N. J., Felbor, U., Whelan, S. P., and Cunningham, J. M. (2005). Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 308, 1643-1645.
13. Côté, M., Misasi, J., Ren, T., Bruchez, A., Lee, K., Filone, C. M., Hensley, L., Li, Q., Ory, D., Chandran, K., and Cunningham, J. (2011). Small molecule inhibitors reveal Niemann-Pick C1 isessential for Ebola virus infection. Nature 477, 344-348.
14. Dominguez-Soto, A., Aragoneses-Fenoll, L., Martin-Gayo, E., Martinez-Prats, L., Colmenares, M., Naranjo-Gomez, M., Borras, F. E., Munoz, P., Zubiaur, M., Toribio, M. L., Delgado, R., and Corbi, A. L. (2007). The DC-SIGN-related lectin LSECtin mediates antigen capture and pathogen binding by human myeloid cells. Blood 109, 5337-5345.
15. Dube, D., Brecher, M. B., Delos, S. E., Rose, S. C., Park, E. W., Schornberg, K. L., Kuhn, J. H., and White, J. M. (2009). The primed Ebolavirus glycoprotein (19-kilodalton GP1,2): sequence and residues critical for host cell binding. J. Virol. 83, 2883-2891.
16. Ebihara, H., Takada, A., Kobasa, D., Jones, S., Neumann, G., Theri-ault, S., Bray, M., Feldmann, H., and Kawaoka, Y. (2006). Molecular determinants of Ebola virus virulence in mice. PLoS Pathog. 2, e73. doi:10.1371/journal.ppat.0020073
17. Eggleton, P., Reid, K. B., and Tenner, A. J. (1998). C1q - how many functions? How many receptors? Trends Cell Biol. 8, 428-431.
18. Fanger, M. W., and Guyre, P. M. (1992). "Fc receptors," in Encyclopedia of Immunology, eds I. M. Roitt and P. J. Delves (San Diego: Academic Press), 544-549.
19. Feldmann, H., Jones, S. M., Daddario-DiCaprio, K. M., Geisbert, J. B., Ströher, U., Grolla, A., Bray, M., Fritz, E. A., Fernando, L., Feldmann, E, Hensley, L. E., and Geisbert, T. W. (2007). Effective post-exposure treatment of Ebola infection. PLoS Pathog. 3, e2. doi:10.1371/journal.ppat.0030002
20. Fisher-Hoch, S., and McCormick, J. (1999). Experimental Filovirus infections. Curr. Top. Microbiol. Immunol. 235,117-143.
21. Fukuyama, S., and Kawaoka, Y. (2011). The pathogenesis of influenza virus infections: the contributions of virus and host factors. Curr. Opin. Immunol. 23,481-486.
22. Geisbert, T. W., and Hensley, L. E. (2004). Ebola virus: new insights into disease etiopatho logy and possible therapeutic interventions. Expert Rev. Mol. Med. 6, 1-24.
23. Gramberg, T., Hofmann, H., Möller, P., Lalor, P. F., Marzi, A., Geier, M., Krumbiegel, M., Winkler, T., Kirchhoff, F., Adams, D. H., Becker, S., Münch, J., andPöhlmann, S. (2005). LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus. Virology 340, 224-236.
24. Gramberg, T., Soilleux, E., Fisch, T., Lalor, P. F., Hofmann, H., Wheeldon, S., Cotterill, A., Wegele, A., Winkler, T., Adams, D. H., and Pöhlmann, S. (2008). Interactions of LSECtin and DC-SIGN/DC-SIGNR with viral lig-ands: differential pH dependence, internalization and virion binding. Virology 373, 189-201.
25. Hevey, M., Negley, D., Geisbert, J., Jahrling, P., and Schmaljohn, A. (1997). Antigenicity and vaccine potential of Marburg virus glycoprotein expressed by bac-ulovirus recombinants. Virology 239,206-216.
26. Hoenen, T., Groseth, A., Falzarano, D., and Feldmann, H. (2006). Ebola virus: unravelling pathogenesis to combat a deadly disease. Trends Mol. Med. 12,206-215.
27. Hunt, C. L., Kolokoltsov, A. A., Davey, R. A., and Maury, W (2011). The Tyro3 receptor kinase Axl enhances macropinocytosis of Zaire ebolavirus. J. Virol. 85, 334-347.
28. Ito, H., Watanabe, S., Sanchez, A., Whitt, M., and Kawaoka, Y. (1999). Mutational analysis of the putative fusion domain of Ebola virus glycoprotein. J. Virol. 73, 8907-8912.
29. Jones, S. M., Feldmann, H., Ströher, U., Geisbert, J. B., Fernando, L., Grolla, A., Klenk, H. D., Sullivan, N. J., Volchkov, V. E., Fritz, E. A., Dad-dario, K. M., Hensley, L. E., Jahrling, P. B., and Geisbert, T. W (2005). Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat. Med. 11,786-790.
30. Kobinger, G. P., Leung, A., Neufeld, J., Richardson, J. S., Falzarano, D., Smith, G., Tierney, K., Patel, A., and Weingartl, H. M. (2011). Replication, pathogenicity, shedding, and transmission of Zaire ebolavirus in pigs. J. Infect. Dis. 204, 200-208.
31. Kondratowicz, A. S., Lennemann, N. J., Sinn, P. L., Davey, R. A., Hunt, C. L., Moller-Tank, S., Meyerholz, D. K., Rennert, P., Mullins, R. F., Brind-ley, M., Sandersfeld, L. M., Quinn, K., Weller, M., McCray, P. B. Jr., Chiorini, J., and Maury, W. (2011). T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire ebolavirus and Lake Victoria Marburg virus. Proc. Natl. Acad. Sci. U.S.A. 108,8426-8431.
32. Kuhn, J. H., Radoshitzky, S. R., Guth, A. C., Warfield, K. L., Li, W., Vincent, M. J., Towner, J. S., Nichol, S. T., Bavari, S., Choe, H., Aman, M. J., andFarzan, M. (2006). Conserved receptor-binding domains of Lake Victoria Marburg virus and Zaire ebolavirus bind a common receptor. J. Biol. Chem.281, 15951-15958.
33. Lee, J. E., Fusco, M. L., Hessell, A. J., Oswald, W B., Burton, D. R., and Saphire, E. O. (2008). Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 454, 177-182.
34. Leroy, E. M., Kumulungui, B., Pourrut, X., Rouquet, P., Hassanin, A., Yaba, P., Délicat, A., Paweska, J. T., Gonzalez, J. P., and Swanepoel, R. (2005). Fruit bats as reservoirs of Ebola virus. Nature 438, 575-576.
35. Leroy, E. M., Rouquet, P., Formenty, P., Souquière, S., Kilbourne, A., Froment, J. M., Bermejo, M., Smit, S., Karesh, W., Swanepoel, R., Zaki, S. R., and Rollin, P. E. (2004). Multiple Ebola virus transmission events and rapid decline of central African wildlife. Science 303, 387-390.
36. Lin, G., Simmons, G., Pöhlmann, S., Baribaud, F., Ni, H., Leslie, G. J., Hag-garty, B. S., Bates, P., Weissman, D., Hoxie, J. A.,andDoms, R. W (2003). Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR. J. Virol. 77, 1337-1346.
37. Linger, R. M., Keating, A. K., Earp, H. S., and Graham, D. K. (2008). TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer. Adv. Cancer Res. 100,35-83.
38. Manicassamy, B., Wang, J., Rum-schlag, E., Tymen, S., Volchkova, V., Volchkov, V., and Rong, L. (2007). Characterization of Marburg virus glycoprotein in viral entry. Virology 358, 79-88.
39. Marzi, A., Akhavan, A., Simmons, G., Gramberg, T., Hofmann, H., Bates, P., Lingappa, V R., and Pöhlmann, S. (2006). The signal peptide of the Ebola virus glycoprotein influences interaction with thecellular lectins DC-SIGN and DC-SIGNR. J. Virol. 80,6305-6317.
40. Marzi, A., Gramberg, T., Simmons, G., Möller, P., Rennekamp, A. J., Krumbiegel, M., Geier, M., Eisemann, J., Turza, N., Saunier, B., Steinkasserer, A., Becker, S., Bates, P., Hofmann, H., and Pöhlmann, S. (2004). DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus. J. Virol. 78, 12090-12095.
41. Marzi, A., Möller, P., Hanna, S. L., Harrer, T., Eisemann, J., Steinkasserer, A., Becker, S., Baribaud, F., and Pöhlmann, S. (2007). Analysis of the interaction of Ebolavirus glycoprotein with DC-SIGN (dendriticcell-specific intercellular adhesion molecule 3-grabbing nonintegrin) and itshomologue DC-SIGNR. J. Infect. Dis. 196(Suppl.2), S237-S246.
42. Matsuno, K., Kishida, N., Usami, K., Igarashi, M., Yoshida, R., Nakayama, E., Shimojima, M., Feldmann, H., Irimura, T., Kawaoka, Y., and Takada, A. (2010a). Different potential of C-type lectin-mediated entry between Marburg virus strains. J. Virol. 84, 5140-5147.
43. Matsuno, K., Nakayama, E., Noyori, O., Marzi, A., Ebihara, H., Irimura, T., Feldmann, H., and Takada, A. (2010b). C- type lectins do not act as functional receptors for filovirus entry into cells. Biochem. Biophys. Res.Commun. 403, 144-148.
44. Michelow, I. C., Lear, C., Scully, C., Prugar, L. I., Longley, C. B., Yan-tosca, L. M., Ji, X., Karpel, M., Brudner, M., Takahashi, K., Spear, G. T., Ezekowitz, R. A., Schmidt, E. V., and Olinger, G. G. (2011). High-dose mannose-binding lectin therapy for Ebola virus infection. J. Infect. Dis. 203, 175-179.
45. Nakayama, E., Tomabechi, D., Matsuno, K., Kishida, N., Yoshida, R., Feldmann, H., and Takada, A. (2011). Antibody-dependent enhancement of Marburg virus infection. J. Infect. Dis. 204(Suppl.3), S978-S985.
46. Nakayama, E., Yokoyama, A., Miyamoto, H., Igarashi, M., Kishida, N., Mat-suno, K., Marzi, A., Feldmann, H., Ito, K., Saijo, M., and Takada, A. (2010). Enzyme-linked immunosor-bent assay for detection of filovirus species-specific antibodies. Clin. Vac. Immunol. 17,1723-1728.
47. Nanbo, A., Imai, M., Watanabe, S., Noda, T., Takahashi, K., Neumann, G., Halfmann, P., and Kawaoka, Y. (2010). Ebola virus is internalized into host cells via macropinocyto-sis in a viral glycoprotein-dependent manner. PLoS Pathog. 6, e1001121. doi:10.1371/journal.ppat.1001121
48. Nicholson-Weller, A., and Klickstein, L. B. (1999). C1q-binding proteins and C1qreceptors. Curr. Opin. Immunol. 11,42-46.
49. Noda, T., Ebihara, H., Muramoto, Y., Fujii, K., Takada, A., Sagara, H., Kim, J. H., Kida, H., Feldmann, H., and Kawaoka, Y (2006). Assembly and budding of Ebola virus. PLoS Pathog. 2, e99. doi:10.1371/journal.ppat.0020099
50. Olinger, G. G., Bailey, M. A., Dye, J. M., Bakken, R., Kuehne, A., Kondig, J., Wilson, J., Hogan, R. J., and Hart, M. K. (2005). Protective cytotoxic T-cell responses induced by venezuelan equine encephalitis virus replicons expressing Ebola virus proteins. J. Virol. 79, 14189-14196.
51. Powlesland, A. S., Fisch, T., Taylor, M. E., Smith, D. F., Tissot, B., Dell, A., Pöhlmann, S., and Drickamer, K. (2008). A novel mechanism for LSECtin binding to Ebola virus surface glycoprotein through truncated glycans. J. Biol. Chem. 283, 593-602.
52. Reed, D. S., and Mohamadzadeh, M. (2007). Status and challenges of filovirus vaccines. Vaccine 25, 1923-1934.
53. Saeed, M. F., Kolokoltsov, A. A., Albrecht, T.,andDavey, R. A. (2010). Cellular entry of Ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes. PLoS Pathog. 6, e1001110. doi:10.1371/journal.ppat.1001110
54. Sanchez, A., Geisbert, T. W., and Feldmann, H. (2007). "Filoviri-dae: Marburg and Ebola viruses," in Fields Virology, 5th Edn, eds D.M. Knipe and P. M. Howley (Philadelphia: Lippincott-Williams &Wilkins), 1409-1448.
55. Sanchez, A., Trappier, S. G., Mahy, B. W., Peters, C.J., and Nichol, S.T. (1996). The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc. Natl. Acad. Sci. U.S.A. 93, 3602-3607.
56. Sanchez, A., Trappier, S. G., Stroher, U., Nichol, S. T., Bowen, M. D., and Feldmann, H. (1998). Variation in the glycoprotein and VP35 genes of Marburg virus strains. Virology 240, 138-146.
57. Schornberg, K., Matsuyama, S., Kabsch, K., Delos, S., Bouton, A., and White, J. (2006). Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein. J. Virol. 80, 4174-4178.
58. Shimojima, M., Takada, A., Ebihara, H., Neumann, G., Fujioka, K., Irimura, T., Jones, S., Feldmann, H., and Kawaoka, Y (2006). Tyro3 family-mediated cell entry of Ebola and Marburg viruses. J. Virol. 80, 10109-10116.
59. Simmons, G., Reeves, J. D., Grogan, C. C., Vandenberghe, L. H., Baribaud, E, Whitbeck, J. C., Burke, E., Buchmeier, M. J., Soilleux, E. J., Riley, J. L., Doms, R. W., Bates, P., and Pöhlmann, S. (2003a). DC-SIGN and DC-SIGNR bind Ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology 305, 115-123.
60. Simmons, G., Rennekamp, A. J., Chai, N., Vandenberghe, L. H., Riley, J. L., and Bates, P. (2003b). Folate receptor alpha and caveolae are not required for Ebola virus glycoprotein-mediated viral infection. J. Virol. 77, 13433-13438.
61. Simmons, G., Wool-Lewis, R. J., Baribaud, F., Netter, R. C., and Bates, P. (2002). Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence. J. Virol. 76, 2518-2528.
62. Sinn, P. L., Hickey, M. A., Staber, P. D., Dylla, D. E., Jeffers, S. A., Davidson, B. L., Sanders, D. A., and McCray, P. B. Jr. (2003). Lentivirus vectors pseudotyped with filoviral envelope glycoproteins transducer airway epithelia from the apical surface independently of folate receptor alpha. J. Virol. 77, 5902-5910.
63. Subbotina, E., Dadaeva, A., Kachko, A., and Chepurnov, A. (2010). Genetic factors of Ebola virus virulence in guinea pigs. Virus Res. 153,121-133.
64. Sullivan, N. J., Geisbert, T. W., Geisbert, J. B., Shedlock, D. J., Xu, L., Lamoreaux, L., Custers, J. H., Popernack, P. M., Yang, Z. Y., Pau, M. G., Roederer, M., Koup, R. A., Goudsmit, J., Jahrling, P. B., and Nabel, G. J. (2006). Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs. PLoS Med. 3, e177. doi:10.1371/journal.pmed.0030177
65. Sullivan, N. J., Geisbert, T. W., Geisbert, J. B., Xu, L., Yang, Z. Y., Roederer, M., Koup, R. A., Jahrling, P. B., and Nabel, G. J. (2003). Accelerated vaccination for Ebola virus hamor-rhagic fever in non-human primates. Nature 424, 681-684.
66. Sullivan, N. J., Sanchez, A., Rollin, P. E., Yang, Z. Y., and Nabel, G. J. (2000). Development of a preventive vaccine for Ebola virus infection in primates. Nature 408, 605-609.
67. Takada, A., Ebihara, H., Feldmann, E, Geisbert, T. W., and Kawaoka, Y. (2007). Epitopes required for antibody-dependent enhancement of Ebola virus infection. J. Infect. Dis. 196(Suppl. 2), S347-S356.
68. Takada, A., Feldmann, H., Ksiazek, T. G., and Kawaoka, Y (2003a). Antibody-dependent enhancement of Ebola virus infection. J. Virol. 77, 7539-7544.
69. Takada, A., Feldmann, H., Stroeher, U., Bray, M., Watanabe, S., Ito, H., McGregor, M., and Kawaoka, Y. (2003b). Identification of protective epitopes on Ebola virus glycoprotein at the single amino acid level by using recombinant vesicular stomatitis viruses.J. Virol. 77,1069-1074.
70. Takada, A., Fujioka, K., Tsuiji, M., Morikawa, A., Higashi, N., Ebihara, H., Kobasa, D., Feldmann, H., Irimura, T., and Kawaoka, Y. (2004). Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry. J. Virol. 78, 2943-2947.
71. Takada, A., and Kawaoka, Y. (2001). The pathogenesis of Ebola hemorrhagic fever. Trends Microbiol. 9, 506-511.
72. Takada, A., and Kawaoka, Y (2003). Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications. Rev. Med. Virol. 13, 387-398.
73. Takada, A., Robison, C., Goto, H., Sanchez, A., Murti, K. G., Whitt, M. A., and Kawaoka, Y. (1997). A system for functional analysis of Ebola virus glycoprotein. Proc. Natl. Acad. Sci. U.S.A. 94, 14764-14769.
74. Takada, A., Watanabe, S., Okazaki, K., Kida, H., and Kawaoka, Y (2001). Infectivity-enhancing antibodies to Ebola virus glycoprotein. J. Virol. 75, 2324-2330.
75. Towner, J. S., Amman, B. R., Sealy, T. K., Carroll, S. A., Comer, J. A., Kemp, A., Swanepoel, R., Paddock, C. D., Balinandi, S., Khristova, M. L., Formenty, P. B., Albarino, C. G., Miller, D. M., Reed, Z. D., Kayiwa, J. T., Mills, J. N., Cannon, D. L., Greer, P. W., Byaruhanga, E., Farnon, E. C., Atimnedi, P., Okware, S., Katongole-Mbidde, E., Downing, R., Tappero, J. W., Zaki, S. R., Ksiazek, T. G., Nichol, S. T., and Rollin, P. E. (2009). Isolation of genetically diverse Marburg viruses from Egyptian fruit bats. PLoS Pathog. 5, e1000536. doi:10.1371/journal.ppat.1000536
76. Towner, J. S., Sealy, T. K., Khristova, M. L., Albariño, C. G., Conlan, S., Reeder, S. A., Quan, P. L., Lipkin, W I., Downing, R., Tappero, J. W., Okware, S., Lutwama, J., Bakamutumaho, B., Kayiwa, J., Comer, J. A., Rollin, P. E., Ksiazek, T. G., and Nichol, S. T. (2008). Newly discovered Ebola virus associated with hemorrhagic fever outbreak in Uganda. PLoS Pathog. 4, e1000212. doi:10.1371/journal.ppat.1000212
77. Usami, K., Matsuno, K., Igarashi, M., Denda-Nagai, K., Takada, A., and Irimura, T. (2011). Involvement of viral envelope GP2 in Ebola virus entry into cells expressing the macrophage galactose-type C-type lectin. Biochem. Biophys. Res. Com-mun.407, 74-78.
78. Volchkov, V E., Chepurnov, A. A., Volchkova, V A., Ternovoj, V A., and Klenk, H.D. (2000). Molecular characterization of guinea pig-adapted variants of Ebola virus. Virology 277, 147-155.
79. Volchkov, V E., Feldmann, H., Volchkova, V A., and Klenk, H. D. (1998). Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc. Natl. Acad. Sci. U.S.A.95, 5762-5767.
80. Warfield, K. L., Bradfute, S. B., Wells, J., Lofts, L., Cooper, M. T., Alves, D. A., Reed, D. K., VanTongeren, S. A., Mech, C. A., and Bavari, S. (2009). Development and characterization of a mouse model for Marburg hemorrhagic fever. J. Virol. 83, 6404-6415.
81. Weissenhorn, W., Carfí, A., Leem, K. H., Skehelm, J. J., and Wiley, D. C. (1998). Crystal structure of the Ebola virus membrane fusion sub- unit, GP2,from the envelope glycoprotein ectodomain. Mol. Cell 2, 605-616.
82. Wool-Lewis, R.J., and Bates, P. (1998). Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines. J. Virol. 72, 3155-3160.
83. Yang, Z.Y., Duckers, H.J., Sullivan, N. J., Sanchez, A., Nabel, E.G., and Nabel, G.J. (2000). Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nat. Med. 6, 886-889.